title: The past, present and future of augmentation cystoplasty.
abstract: What's known on the subject? And what does the study add? There is a wealth of evidence on the development, indications, outcomes and complications of augmentation cystoplasty (AC). Over the last decade, new evidence has been emerging to influence our clinical practice and application of this technique. AC is indicated as part of the treatment pathway for both neurogenic and idiopathic detrusor overactivity, usually where other interventions have failed or are inappropriate. The most commonly used technique remains augmentation with a detubularised patch of ileum (ileocystoplasty). Controversy persists over the role of routine surveillance following ileocystoplasty for the detection of subsequent bladder carcinoma; however the indication for surveillance after gastrocystoplasty is clearer due to a rising incidence of malignancy in this group. Despite a reduction in the overall numbers of AC operations being performed, it clearly still has a role to play, which we re-examine with contemporary studies from the last decade.
authors: Department of Urology, Leicester General Hospital, Leicester, UK. suzannebiers@hotmail.com
authors: Suzanne M
authors: SM
authors: Biers
authors: Suzie N
authors: SN
authors: Venn
authors: Tamsin J
authors: TJ
authors: Greenwell
mesh_terms: D006801:Humans; D011183:Postoperative Complications; D051437:Renal Insufficiency / Q000150:complications; D001745:Urinary Bladder Diseases / Q000209:etiology; D053201:Urinary Bladder, Overactive / Q000150:complications / Q000601:surgery*; D014545:Urinary Calculi / Q000209:etiology; D013520:Urologic Surgical Procedures / Q000009:adverse effects / Q000379:methods*